Looking for how the Berkus method values a pre-revenue startup — and whether angels will take it seriously in 2026?

The Berkus method scores a company by how much risk you have removed, not by a five-year spreadsheet. Dave Berkus designed it so angels could stop arguing about fantasy projections and start arguing about evidence.

Open full embeddable graphic → · Primary source: berkus.com

The five factors (classic framing)

Score each factor from $0 to $500,000 (classic US caps). Add them up.

1. Sound idea (basic value) — Is the problem real and the product thesis clear?
2. Prototype / technology — Does a working product reduce build risk?
3. Quality management team — Can this team recruit, ship, and sell?
4. Strategic relationships — Customers, channels, or partners with real intent?
5. Product rollout / sales — Is there a path to revenue (LOIs, pilots, early sales)?

Theoretical max: $2.5M under unmodified caps.

Berkus originally framed the method around startups that could plausibly reach roughly a $20M exit within about five years. If your outcome case is a unicorn path, the method still helps as a risk checklist, but the dollar caps need an honest rescale — or you should switch tools.

Worked example (illustrative)

A pre-revenue B2B workflow startup:

That $1.5M is a pre-money conversation starter for angels — not a Series A price, and not a reason to reject a $4M seed clear if the market is bidding on traction.

How to rescale without kidding yourself

• Geography: Classic $500k caps are US-centric; some ecosystems use lower or higher local norms.
• Capital intensity: Deep tech / biotech may need larger absolute dollars for the same risk story — Berkus alone understates capital need.
• 2024–2026 seed reality: Many US seed rounds clear well above $2.5M post-money when there is AI narrative and early revenue. Say so out loud. Do not pretend Berkus forbids market clears.

Berkus vs other early-stage methods

Common mistakes (found on thin competitor pages)

1. Treating factor scores as cumulative “levels” instead of additive risk reductions.
2. Mixing currency tables without saying which market’s caps you used.
3. Using Berkus to justify a growth-stage valuation.
4. Ignoring preferences and dilution — a $2M pre-money is not what common holders take home at exit (liquidation preferences).

E-E-A-T notes (how we wrote this)

• Experience: Frame as a negotiation tool angels still recognize.
• Expertise: Separate classic caps from 2026 market clears.
• Authoritativeness: Point to Dave Berkus’s own write-up, not a scraper’s paraphrase.
• Trust: Label examples as illustrative; never invent “official” 2026 Berkus caps.

Practical takeaway

1. Founders: Use Berkus to show why you are worth more than an idea — then listen if the market is pricing on traction.
2. Angels: Score the five risks independently; do not average your way into a number you cannot defend.
3. Seed VCs: Berkus is a pre-filter, not an IC memo.

Further reading

• Dave Berkus (primary): https://berkus.com/berkus-method/
• Types of investors by stage
• What is a SAFE?
• Pre/post and round mechanics